Ellsworth Advisors »

Arrivent Biopharma shares owned by Ellsworth Advisors

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Ellsworth Advisors from 13F filings

Historical chart of Ellsworth Advisors investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Ellsworth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Ellsworth Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $890k 27k 32.95

More positions owned by Ellsworth Advisors

Harbor Etf Trust Comm All Wea Etf (HGER)
Spdr Gold Tr Gold Shs (GLD)
NVIDIA Corporation (NVDA)
Apple (AAPL)
First Tr Exchange-traded First Tr Enh New (FTSM)
Dell Technologies CL C (DELL)
Johnson & Johnson (JNJ)
Broadcom (AVGO)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Goldman Sachs (GS)
Cisco Systems (CSCO)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Enterprise Products Partners (EPD)

View all positions for Ellsworth Advisors

Top funds holding Arrivent Biopharma

Suvretta Capital Management
Infinitum Asset Management
Hillhouse Capital Advisors
OrbiMed Advisors
FMR
BlackRock
Octagon Capital Advisors
Novo A/S
Sofinnova Ventures
Vanguard Capital Management
General Catalyst Group Management
State Street Corporation
Vivo Capital
Goldman Sachs Group
Geode Capital Management

View all funds holding Arrivent Biopharma